TrialBreast cancer (Tokyo, Japan)2023

CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.

Caroline Bailleux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.